dongsheng
Posts:21
My father is a adeno lung cancer patient, and I recently visited him in China. While I was there, the hospital where my father is receiving his treatment offered a treatment called "Cascade Primed Immune Cells" (CAPRI ). The brochure said this treatment is invented by Dr.Rudolf Wank from Munich Center of Immunotherapy Germany.
I found very limited information on internet regarding its efficacy in treating lung cancer. I am wonder if anyone has heard of it ? experienced it ? and how you think of it ?
Forums
Reply # - May 14, 2013, 08:35 PM
Reply To: Cascade Primed Immune Cells ( CAPRI)
I have never heard of it. I would venture to say that it is not an established or widely recommended treatment at this point.
-Dr. West
Reply # - May 15, 2013, 08:47 AM
Reply To: Cascade Primed Immune Cells ( CAPRI)
Thank you for the feedback
Reply # - May 5, 2014, 05:00 AM
Reply To: Cascade Primed Immune Cells ( CAPRI)
I've just read about it here:
http://www.jmedicalcasereports.com/content/7/1/266
It seems very promising (but of course, I'm no doctor). A person with Pancoast's survived for 10+ years after surgery on this therapy. The authors suggests immune cells need to be isolated from blood before chemo for best results.
I wish it was available in my country. But it's probably very expensive.
Reply # - May 5, 2014, 05:31 AM
Reply To: Cascade Primed Immune Cells ( CAPRI)
Hi andrius,
Anecdotal evidence from four patients is not especially helpful to determine whether a particular treatment has been successful, especially when those patients were also treated with either surgery, radiation or chemotherapy, or some combination of those therapies. Only a clinical trial, in which a number of patients with similar situations are randomized to receive either the trial therapy or an alternate (or placebo), can provide solid evidence of that treatment's efficacy.
I should also point out that the first sentence of the report ("Despite newer treatment modalities, few patients with non-small cell lung cancer in stages IIIB and IV survive the median of one year.") is not at all accurate - the median survival for stage IV patients is near a year, and that means that half survive longer than a year, a fact that should be well known to the authors of the study.
JimC
Forum moderator